YPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astellas Pharma Inc

Watchlist Manager

Watchlist

Price: 14.2 EUR Market Closed

Market Cap: €25.4B

	Astellas Pharma Inc F:YPHA	JP
R	Royal Unibrew A/S F:0R1	DK
P	Prada SpA XMUN:PRP	IT
S	Skyworks Solutions Inc XMUN:AWM	US
C	CSW Industrials Inc F:UCI	US
	Time Out Group PLC F:05T	UK
	White Cliff Minerals Ltd OTC:WCMLD	AU
F	Foundation Healthcare Holdings Ltd F:C5Y	SG
	Monadelphous Group Ltd OTC:MDPHF	AU
	Scinai Immunotherapeutics Ltd F:2F50	IL
R	Red Planet Japan Inc SWB:DN3	JP
	Maeda Kosen Co Ltd TSE:7821	JP
T	Trans Oceans Tours SAE EGX:TRTO	EG

Profitability Summary

Astellas Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

81%

Declining Gross Margin

82% > 81%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

10% > 21%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

4% > 16%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.